In this review, we also described how HER2 interacts with stemness signaling such as TGF-β/Smad, Notch, Wnt/β-catenin and JAK/STAT pathways in epithelial BC cell to induce EMT and how this phenomenon leads to trastuzumab resistance (Figure 2). The gene discussed is ERBB2; the disease is breast cancer.